Skip To Main Content
Lauren Biscaldi on Muck Rack

Lauren Biscaldi

(She/Her)
New Jersey, New York
As seen in: The Michael J. Fox Foundation for Parkinson's Research, Psychiatric Times, The Clinical Advisor, American Journal of Managed Care, Infection Control Today, Monthly Prescribing Reference, Cancer Therapy Advisor, Contemporary OB/GYN, Psychiatry Advisor, Dermatology Times, Renal & Urology News and
Covers:  I cover all aspects of healthcare and life sciences, including pharmacy, primary care, oncology, dermatology, infectious diseases, and healthcare policy.
Lead editor @MichaelJFoxOrg. @NewhouseSU alum (G'20). Dog mom.

Get in touch with Lauren

Contact Lauren, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Secukinumab Plus Glucocorticoid Taper for Relapsed Polymyalgia Rheumatica

|
By Lauren Biscaldi
| medicalbag.com
In patients with recently relapsed polymyalgia rheumatica, secukinumab plus a 24-week glucocorticoid taper is more effective and more likely to lead to sustained remission than a glucocorticoid taper alone, according to research results published in the New England Journal of Medicine.
Open in Who Shared Issue with article?

Long-Term Data Support Certolizumab Pegol Use in Pediatric Juvenile Idiopathic Arthritis

|
By Lauren Biscaldi
| Rheumatology Advisor Verified
Certolizumab pegol (CZP) is safe, effective, and tolerable in polyarticular-course juvenile idiopathic arthritis (JIA), demonstrating rapid long-term clinical improvements, according to research results published in Arthritis & Rheumatology.
Open in Who Shared Issue with article?

Secukinumab Plus Glucocorticoid Taper for Relapsed Polymyalgia Rheumatica

|
By Lauren Biscaldi
| Rheumatology Advisor Verified
In patients with recently relapsed polymyalgia rheumatica, secukinumab plus a 24-week glucocorticoid taper is more effective and more likely to lead to sustained remission than a glucocorticoid taper alone, according to research results published in the New England Journal of Medicine.
Open in Who Shared Issue with article?
See all 1,222 licensed articles (1,456 Total)